Biotech, cancer, Inflammation Luke Timmerman wrote: Some members of the band that pumped out a one-hit wonder at Icos are getting back together to see if they can produce at least one more hit at Seattle-based Calistoga Pharmaceuticals. Calistoga has been building up its management team over the pas...

Software, IT, strategy Gregory T. Huang wrote: On Tuesday night, I attended an intriguing event in the Washington Technology Industry Association’s cloud computing series, on “Scaling Into the Cloud with Amazon Web Services.” It was held at Amazon’s Beacon Hill headquarters i...

Biotech, Drugs, Life Sciences Stewart Lyman wrote: Seattle’s biotech community used to be among the top-ranked in the nation. But as some 2,500 layoffs have piled up in the local biotech sector since 2002, Seattle has tumbled in the rankings. We need to face up to this fact first, before we ca...

Tonight we won Cork emerging company of the year presented by The Cork Chamber. It was an excellent event and huge congrats to Chairman Joe Gantly and his team for running an event of this size, nearly 1000 people sat down for dinner. Digicel Chairman Denis O Brien was the guest of honor and made an...

Biotech, acquisitions, diabetes Luke Timmerman wrote: Carl Icahn has sized up one of San Diego’s biggest biotech companies, Amylin Pharmaceuticals, in the crosshairs. The famed billionaire investor said today he has bought up an 8 percent stake in the company, and that he intends to nominate a...

The Wall Street Journal reports that Wyeth, desperate to make money off of its Effexor XR-knockoff, Pristiq, says it will slash the antidepressant at a 20% discount compared to Effexor's price. The price slash, CNN money reports, is a result......